Communicating information about drug interactions
نویسندگان
چکیده
منابع مشابه
Communicating information about “what not to do” to consumers
BACKGROUND Americans devote more resources to health care than any other developed country, and yet they have worse health outcomes and less access. This creates a perfect set of opportunities for Consumer Reports, a nonprofit consumer advocacy and multimedia organization known for its focus on individual consumers in markets where significant amounts of misinformation is in play. Consumer Repo...
متن کاملPatient counseling about herbal-drug interactions.
Many people have the mistaken notion that, being natural, all herbs and foods are safe; this is not so. Very often, herbs and food may interact with medications you normally take, result in serious reactions. During the latter part of this century the practice of herbalism has become mainstream throughout the world. This is due remove to the recognition of the value of traditional medical syste...
متن کاملCommunicating about screening.
People are offered a wide range of screening tests by diverse providers. For example: maternal and child health services screen for genetic conditions and developmental problems; general practitioners screen for cardiovascular risk factors; NHS programmes screen for bowel, breast, and cervical cancer; and commercial providers offer various health assessments, including body and gene scans. Prov...
متن کاملCommunicating generalizations about events
Habitual sentences (e.g. Bill smokes.) generalize an event over time, but how do you know when a habitual sentence is true? We develop a computational model and use this to guide experiments into the truth conditions of habitual language. In Expts. 1 & 2, we measure participants’ prior expectations about the frequency with which an event occurs and validate the predictions of the model for when...
متن کاملFormalizing Knowledge and Evidence about Potential Drug-drug Interactions
Potential drug-drug interactions (PDDI) are a significant source of preventable drug-related harm. One contributing factor is that there is no standard way to represent PDDI knowledge claims and associated evidence in a computable form. The research we present in this paper addresses this problem by creating a new version of the Drug Interaction Knowledge Base, with scalable, interlinkable repo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2007
ISSN: 0306-5251,1365-2125
DOI: 10.1111/j.1365-2125.2007.02948.x